Global Antidiabetics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Product;

Insulin - Rapid Acting Analog, Long Acting Analog, Premixed Insulin, Short Acting Analog and Intermediate Acting Analog, Drug Class - Alpha Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 (Glucagon Like Peptide) Agonists, DPP-Iv (Dipeptidyl Peptidase) Inhibitors, Meglitinides, SGLT-Ii (Sodium Glucose Transport Proteins) Inhibitors and Thiazolidinedione.

Segmented by Patient Population;

Pediatric, Adult and Geriatric.

Segmented by Administration Route;

Insulin Syringe/ Insulin Pen, Insulin Pump, Intravenous Infusion, Oral and Others.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn477397599 Published Date: March, 2024 Updated Date: April, 2024

Introduction

Global Antidiabetics Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 56.7
2021 61.8
2022 72.2
2023 84.0
2024 86.5
2025 102.9
2026 110.0
2027 128.9
2028 152.7
2029 153.6
2030 155.9

In the year 2023, the Global Antidiabetics Market was valued at USD 74,833.07 million. The size of this market is expected to increase to USD 126,597.43 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.8%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Patient Population
    3. Market Snapshot, By Administration Route
    4. Market Snapshot, By Region
    5. Market Opportunity Map
  4. Global Antidiabetics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Strong product pipeline of antidiabetics
        2. Globally rising prevalence of diabetes
        3. Increasing prevalence of lifestyle induced disorders such as obesity
        4. Growing adoption of oral antidiabetic drugs
        5. Rising spending on R&D for innovative drugs
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Antidiabetics Market, By Product, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Insulin
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. Rapid Acting Analog
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. Long Acting Analog
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            3. Premixed Insulin
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            4. Short Acting Analog
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            5. Intermediate Acting Analog
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Drug Class
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. Alpha Glucosidase Inhibitors
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. Biguanides
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            3. Sulphonylureas
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            4. GLP-1 (Glucagon Like Peptide) Agonists
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            5. DPP-Iv (Dipeptidyl Peptidase) Inhibitors
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            6. Meglitinides
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            7. SGLT-Ii (Sodium Glucose Transport Proteins) Inhibitors
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            8. Thiazolidinedione
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Antidiabetics Market, By Patient Population, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Pediatric
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Adult
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Geriatric
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Antidiabetics Market, By Administration Route, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Insulin Syringe/ Insulin Pen
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Insulin Pump
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Intravenous Infusion
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Oral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    4. Global Antidiabetics Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. AstraZeneca
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Bayer Corporation
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Boehringer Ingelheim
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Bristol-Myers Squibb
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Eli Lilly
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Halozyme Therapeutics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Johnson & Johnson
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Merck & Co. Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Novartis AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Novo Nordisk
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      11. Oramed Pharmaceuticals Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      12. Pfizer
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      13. Sanofi
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      14. Takeda Pharmaceutical
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Antidiuretic Drugs
Global Antidiuretic Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Antidiuretic Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Antiemetics
Global Antiemetics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Antiemetics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Anti-Epilepsy Drugs
Global Anti-Epilepsy Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Anti-Epilepsy Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Antifungal Treatment
Global Antifungal Treatment Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Antifungal Treatment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...